AIM ImmunoTech, Inc. (AIM)
0.1626
-0.01
(-4.35%)
USD |
NYAM |
Oct 22, 16:00
0.1626
0.00 (0.00%)
After-Hours: 16:25
AIM ImmunoTech EPS Diluted (Quarterly) : -0.2213 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2213 |
| March 31, 2026 | -0.6947 |
| December 31, 2025 | -1.359 |
| September 30, 2025 | -1.567 |
| June 30, 2025 | -3.676 |
| March 31, 2025 | -0.0527 |
| December 31, 2024 | -9.630 |
| September 30, 2024 | -0.0642 |
| June 30, 2024 | -0.0348 |
| March 31, 2024 | -0.1176 |
| December 31, 2023 | -0.2561 |
| September 30, 2023 | -0.1607 |
| June 30, 2023 | -0.1014 |
| March 31, 2023 | -0.0756 |
| December 31, 2022 | -0.0913 |
| September 30, 2022 | -0.1328 |
| June 30, 2022 | -0.101 |
| March 31, 2022 | -0.0796 |
| December 31, 2021 | -0.1218 |
| September 30, 2021 | -0.08 |
| June 30, 2021 | -0.1228 |
| March 31, 2021 | -0.0783 |
| December 31, 2020 | -0.0933 |
| September 30, 2020 | -0.085 |
| June 30, 2020 | -0.1124 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2177 |
| December 31, 2019 | -10.22 |
| September 30, 2019 | -1.132 |
| June 30, 2019 | -107.12 |
| March 31, 2019 | -2.911 |
| December 31, 2018 | -1.451 |
| September 30, 2018 | -2.870 |
| June 30, 2018 | -2.379 |
| March 31, 2018 | -3.291 |
| December 31, 2017 | -2.64 |
| September 30, 2017 | -1.76 |
| June 30, 2017 | -351.65 |
| March 31, 2017 | -4.84 |
| December 31, 2016 | -2.133 |
| September 30, 2016 | -5.72 |
| June 30, 2016 | -5.28 |
| March 31, 2016 | -5.28 |
| December 31, 2015 | -5.28 |
| September 30, 2015 | -10.56 |
| June 30, 2015 | -10.56 |
| March 31, 2015 | -10.56 |
| December 31, 2014 | -11.53 |
| September 30, 2014 | -10.56 |
| June 30, 2014 | -15.84 |
| March 31, 2014 | -10.56 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.788M |
| Revenue (Quarterly) | 0.026M |
| Total Expenses (Quarterly) | 3.814M |
| Enterprise Value | -1.115M |
| Gross Profit Margin (Quarterly) | -1.95K% |
| Profit Margin (Quarterly) | -14.57K% |
| Earnings Yield | -2.36K% |
| Normalized Earnings Yield | -2242.87 |